Clinical Trials Logo

Liver Fibrosis clinical trials

View clinical trials related to Liver Fibrosis.

Filter by:

NCT ID: NCT03420768 Completed - Liver Fibrosis Clinical Trials

A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C

Start date: February 14, 2018
Phase: Phase 2
Study type: Interventional

This is a study of experimental medication BMS-986263 in adult patients with advanced hepatic fibrosis (scar tissue in the liver caused by inflammation that is far on in progress) after the patient is cured of hepatitis C (an infection caused by a virus that attacks the liver and leads to inflammation).

NCT ID: NCT03389152 Completed - Liver Fibroses Clinical Trials

SWE Liver Stiffness as a Predictor of Progression of Chronic Liver Diseases

SWE Predict
Start date: July 26, 2007
Phase:
Study type: Observational

This study is a multicenter individual patient-based meta-analysis that will assess the performances of liver stiffness measurements performed with supersonic shear imaging shearwave elastography (SSI-SWE) in patients with liver fibrosis to predict progression of chronic liver disease.

NCT ID: NCT03382119 Completed - Liver Fibroses Clinical Trials

Increased Liver Stiffness: A Study of Acoustic Radiation Force Impulse (ARFI) Elastography

Start date: April 11, 2018
Phase:
Study type: Observational

The goal of this study is to determine if ultrasound tools can be used to detect liver stiffness. Acoustic radiation force impulse (ARFI) elastography and backscatter will be used to see if they can detect liver stiffness in different populations of patients with liver disease. The study is measuring liver stiffness in pediatric patients aged 2-5 years. Patients either have had a Fontan cardiac surgery or have liver disease. Ultrasound scanning takes images of the liver and has much lower risks for patients. ARFI elastography and other tools can be used to measure liver stiffness.

NCT ID: NCT03342560 Completed - Liver Diseases Clinical Trials

Beyond Confounders: Addressing Source of Measurement Variability and Error in Shear Wave Elastography

Start date: June 29, 2017
Phase: N/A
Study type: Interventional

Chronic liver disease is a major problem in the general population and there is an unmet need to diagnose(and screen) for liver disease with using noninvasive, cost-effective and sensitive techniques.The investigators hypothesize that variation using ultrasound elastography for the estimation of stage of liver fibrosis and steatosis in patients with diffuse liver disease exists due to different methods of measurements, and/or different systems. The proposed investigation is a cross-sectional study using ultrasound elastography and fat quantification modalities. The investigators are planning to enroll 30 subjects 18 years old and older in whom diffuse liver disease is suspected, and who have undergone non-focal liver biopsy in the past 6 months or are scheduled to undergo biopsy within 3 months of enrollment, as part of their routine clinical care. The investigators will use 4 different ultrasound devices with their shear wave elastography and speed of sound functions. Specific aims; - Compare shear wave elastography(SWE) measurements from different ultrasound systems; using histopathology as reference standards. - Assess intra-operator and inter-operator reliability by measuring variability in elastography values by two operators on a single system. - Determine the effect of deviations from guidelines(less number of measurements and measurements during active breath)

NCT ID: NCT03198104 Completed - Liver Diseases Clinical Trials

Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI

Kids4LIFe
Start date: April 1, 2016
Phase:
Study type: Observational

This is a prospective observational study which will recruit up to 100 paediatric participants over a period of 30 months to determine whether MRI is as accurate at detecting, distinguishing, and monitoring liver disease as current standard of care techniques such as liver biopsy and fibroscan.

NCT ID: NCT03149627 Completed - Alcoholic Hepatitis Clinical Trials

Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults

HEP-ZED
Start date: June 7, 2017
Phase:
Study type: Observational

The purpose of this study is to recruit a random and representative sample of individuals within several Zambian communities for markers of Hepatitis B Virus (HBV) and to characterize chronic HBV infection and indications for treatment.

NCT ID: NCT03047707 Completed - Liver Fibroses Clinical Trials

S-Shearwave Elastography for Assessment of Hepatic Fibrosis

Start date: May 22, 2017
Phase: N/A
Study type: Interventional

The purpose of this multi-center prospective study is to evaluate the diagnostic performance of S-Shearwave, a newly developed ultrasound shear wave elastography, for the assessment of hepatic fibrosis.

NCT ID: NCT02967198 Completed - Liver Fibroses Clinical Trials

Pre-procedure Planning for Liver Biopsy or Radiofrequency Ablation Using CT or MR/US Fusing Imaging

Start date: November 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether fusion technique of preradiofrequency ablation (RFA) or percutaneous liver biopsy cross-sectional imaging (CT or MR) and real-time ultrasonography would improve feasibility of RFA or liver biopsy in patients with liver tumor in comparison with ultrasonography guidance alone. And assessment of a new point shear-wave elastography method (pSWE, S-shear wave) and compare its accuracy in assessing liver stiffness (LS) with another pSWE technique (ARFI).

NCT ID: NCT02603666 Completed - Cystic Fibrosis Clinical Trials

Elastography of the Liver in Cystic Fibrosis Patients. Diagnostic and Prognostic Aspects

Start date: January 2012
Phase: N/A
Study type: Interventional

The aim of the study is to find CF patients at risk for cystic fibrosis related liver disease (CFLD). Comparison of ultrasound by two modalities and biochemical markers with histological evaluation of liver biopsy if present.

NCT ID: NCT02538874 Completed - Liver Fibrosis/NASH Clinical Trials

A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body

Start date: October 31, 2015
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess safety, to measure blood levels of drug, and to find out what the drug does to the body.